Genomic epidemiology of global carbapenemase-producing Escherichia coli, 2015–2017

We are excited to announce that the repository will soon undergo an upgrade, featuring a new look and feel along with several enhanced features to improve your experience. Please be on the lookout for further updates and announcements regarding the launch date. We appreciate your support and look forward to unveiling the improved platform soon.

Show simple item record

dc.contributor.author Peirano, Gisele
dc.contributor.author Chen, Liang
dc.contributor.author Nobrega, Diego
dc.contributor.author Finn, Thomas J.
dc.date.accessioned 2023-06-08T05:12:28Z
dc.date.available 2023-06-08T05:12:28Z
dc.date.issued 2022-05
dc.description.abstract We describe the global molecular epidemiology of 229 carbapenemase-producing Escherichia coli in 36 countries during 2015–2017. Common carbapenemases were oxacillinase (OXA) 181 (23%), New Delhi metallo-β-lactamase (NDM) 5 (20%), OXA-48 (17%), Klebsiella pneumoniae carbapenemase 2 (15%), and NDM-1 (10%). We identified 5 dominant sequence types (STs); 4 were global (ST410, ST131, ST167, and ST405), and 1 (ST1284) was limited to Turkey. OXA-181 was frequent in Jordan (because of the ST410-B4/H24RxC subclade) and Turkey (because of ST1284). We found nearly identical IncX3-blaOXA-181 plasmids among 11 STs from 12 countries. NDM-5 was frequent in Egypt, Thailand (linked with ST410-B4/H24RxC and ST167-B subclades), and Vietnam (because of ST448). OXA-48 was common in Turkey (linked with ST11260). Global K. pneumoniae carbapenemases were linked with ST131 C1/H30 subclade and NDM-1 with various STs. The global carbapenemase E. coli population is dominated by diverse STs with different characteristics and varied geographic distributions, requiring ongoing genomic surveillance. en_US
dc.description.department Medical Microbiology en_US
dc.description.librarian am2023 en_US
dc.description.sponsorship The Joint Programming Initiative on Antimicrobial Resistance–Canadian Institute Health Research program and the US National Institutes of Health. en_US
dc.description.uri http://wwwnc.cdc.gov/eid en_US
dc.identifier.citation Peirano, G., Chen, L., Nobrega, D. et al. 2022, 'Genomic epidemiology of global carbapenemase-producing escherichia coli, 2015–2017', Emerging Infectious Diseases, vol. 28, no. 5, pp. 924-931, doi : 10.3201/eid2805.212535. . en_US
dc.identifier.issn 1080-6040 (print)
dc.identifier.issn 1080-6059 (online)
dc.identifier.other 10.3201/eid2805.212535
dc.identifier.uri http://hdl.handle.net/2263/91048
dc.language.iso en en_US
dc.publisher Centers for Disease Control and Prevention en_US
dc.rights © 2022, Centers for Disease Control and Prevention (CDC). All rights reserved. en_US
dc.subject Surveillance en_US
dc.subject Carbapenemases en_US
dc.subject Molecular epidemiology en_US
dc.subject Escherichia coli en_US
dc.subject Bacteria en_US
dc.subject Whole-genome sequencing (WGS) en_US
dc.subject Antimicrobial resistance (AMR) en_US
dc.title Genomic epidemiology of global carbapenemase-producing Escherichia coli, 2015–2017 en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record